You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 16, 2025

Details for Patent: 10,226,436


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,226,436
Title:Norepinephrine compositions and methods therefor
Abstract:The inventive subject matter is directed to compositions and methods for ready-to-inject norepinephrine compositions with improved stability. Most preferably, compositions presented herein are substantially antioxidant free and exhibit less than 10% isomerization of R-norepinephrine and exhibit less than 5% degradation of total norepinephrine.
Inventor(s):Puri Navneet, Soppimath Kumaresh, Akasapu Prem Sagar, Yadav Vivek, Ilitchev Iouri V., Garapati Sriramya, Hingorani Tushar
Assignee:Nevakar Inc.
Application Number:US15883798
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,226,436

Introduction

United States Patent 10,226,436, titled "Norepinephrine compositions and methods therefor," is a patent that focuses on compositions and methods for ready-to-inject norepinephrine formulations with improved stability. Here, we will delve into the details of the patent's scope, claims, and the broader patent landscape it operates within.

Background of the Patent

The patent, issued to address the need for stable and ready-to-inject norepinephrine compositions, is crucial in the medical field, particularly in emergency and critical care settings. Norepinephrine is a potent vasopressor used to treat severe hypotension and septic shock.

Claims of the Patent

The patent includes several claims that define the scope of the invention. Here are some key aspects:

Independent Claims

  • The patent includes independent claims that describe the composition and method of preparing the norepinephrine formulations. For example, Claim 1 might describe a composition comprising norepinephrine, a stabilizer, and a solvent, while Claim 2 might detail the method of preparing this composition[4].

Dependent Claims

  • Dependent claims build upon the independent claims, adding specific details or limitations. These claims help to narrow down the scope and provide additional protection for the invention. For instance, a dependent claim might specify the concentration of norepinephrine or the type of stabilizer used.

Scope of the Patent

The scope of the patent is defined by the claims and the description provided in the specification.

Composition Claims

  • These claims cover the specific formulations of norepinephrine, including the types and amounts of stabilizers and solvents used. The stability of the composition is a critical aspect, as it ensures the norepinephrine remains effective over time[4].

Method Claims

  • Method claims outline the steps involved in preparing the norepinephrine compositions. This includes any specific conditions, such as temperature, pH, or mixing procedures, that are necessary to achieve the desired stability.

Patent Eligibility and Subject Matter

The patentability of the claims under U.S. law is subject to the guidelines set by the USPTO and recent case law.

Practical Applications

  • To be patent-eligible, the claims must integrate abstract ideas into practical applications. For example, the use of a specific stabilizer to improve the stability of norepinephrine in a ready-to-inject formulation would be considered a practical application, transforming the abstract idea into patent-eligible subject matter[1].

Meaningful Limits

  • The claims must impose meaningful limits on any judicial exceptions (e.g., abstract ideas, natural phenomena) to be considered patent-eligible. In this case, the specific combination of norepinephrine with a stabilizer and solvent, and the method of preparation, would need to demonstrate a clear technological improvement[1].

Inventorship and Ownership

Correct identification of inventors is crucial for the validity and enforceability of the patent.

True and Only Inventors

  • U.S. patent law requires that only the true and only inventors be listed on the patent application. Errors in inventorship, especially those involving deceptive intent, can render the patent unenforceable[2].

Patent Landscape

The patent operates within a broader landscape of pharmaceutical and medical device patents.

Related Patents

  • Other patents in the field of pharmaceutical compositions and medical devices may intersect with this patent. For example, patents related to vasopressors, stabilizers, or injection systems could be relevant[5].

Litigation and Enforcement

  • The enforceability of the patent can be affected by litigation. Cases involving infringement, willfulness, and damages, as seen in other patent disputes, highlight the importance of robust claims and thorough inventorship determination[5].

Metrics for Patent Scope

The scope of the patent can be measured using various metrics.

Claim Length and Count

  • Independent claim length and count are simple metrics that can indicate the breadth and clarity of the patent. Narrower claims are often associated with a higher probability of grant and a shorter examination process[3].

Real-World Applications

The practical applications of the patent are critical for its value and impact.

Improved Stability

  • The ready-to-inject norepinephrine compositions with improved stability have significant real-world benefits, such as enhanced patient care and reduced preparation time in emergency settings.

Key Takeaways

  • Claims and Scope: The patent's claims define its scope, covering specific compositions and methods for preparing stable norepinephrine formulations.
  • Patent Eligibility: The claims must integrate abstract ideas into practical applications and impose meaningful limits to be patent-eligible.
  • Inventorship: Correct identification of inventors is essential for the patent's validity and enforceability.
  • Patent Landscape: The patent operates within a broader landscape of pharmaceutical and medical device patents, with potential intersections and litigation risks.
  • Real-World Impact: The practical applications of the patent improve patient care and emergency response times.

Frequently Asked Questions (FAQs)

Q: What is the main focus of United States Patent 10,226,436? A: The patent focuses on compositions and methods for ready-to-inject norepinephrine formulations with improved stability.

Q: How are the claims of the patent structured? A: The patent includes independent claims that describe the composition and method, and dependent claims that add specific details or limitations.

Q: What are the key factors for patent eligibility in this context? A: The claims must integrate abstract ideas into practical applications and impose meaningful limits to be considered patent-eligible.

Q: Why is correct inventorship important for this patent? A: Correct identification of inventors is essential for the patent's validity and enforceability, as errors involving deceptive intent can render the patent unenforceable.

Q: How does the patent impact real-world applications? A: The ready-to-inject norepinephrine compositions with improved stability enhance patient care and reduce preparation time in emergency settings.

Cited Sources:

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. Determining Inventorship for US Patent Applications - Oregon State University
  3. Patent Claims and Patent Scope - SSRN
  4. US10226436B2 - Norepinephrine compositions and methods therefor - Google Patents
  5. Provisur - United States Court of Appeals for the Federal Circuit - CAFC

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,226,436

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Long Grove Pharms NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE norepinephrine bitartrate SOLUTION;INTRAVENOUS 214628-001 Oct 6, 2022 RX Yes Yes 10,226,436 ⤷  Try for Free Y INDICATED TO RAISE BLOOD PRESSURE IN ADULT PATIENTS WITH SEVERE, ACUTE HYPOTENSION ⤷  Try for Free
Long Grove Pharms NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE norepinephrine bitartrate SOLUTION;INTRAVENOUS 214628-002 Oct 6, 2022 RX Yes Yes 10,226,436 ⤷  Try for Free Y INDICATED TO RAISE BLOOD PRESSURE IN ADULT PATIENTS WITH SEVERE, ACUTE HYPOTENSION ⤷  Try for Free
Long Grove Pharms NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE norepinephrine bitartrate SOLUTION;INTRAVENOUS 214628-003 Oct 6, 2022 RX Yes Yes 10,226,436 ⤷  Try for Free Y INDICATED TO RAISE BLOOD PRESSURE IN ADULT PATIENTS WITH SEVERE, ACUTE HYPOTENSION ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.